Bayer Suit Seeks Damages For Fraud In $1 Bil. Sale Of Chiron Diagnostics Unit
This article was originally published in The Gray Sheet
Executive Summary
Bayer is seeking compensation from Chiron for expenses related to the 1999 recall of the Rapidpoint 400 blood gas analyzer